A detailed history of Tema Etfs LLC transactions in Immunome Inc. stock. As of the latest transaction made, Tema Etfs LLC holds 102,055 shares of IMNM stock, worth $1.75 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares
102,055
Previous 162,186 37.08%
Holding current value
$1.75 Million
Previous $1.9 Billion 15.42%
% of portfolio
0.17%
Previous 0.16%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2025

Jan 16, 2026

SELL
$11.34 - $17.52 $681,885 - $1.05 Million
-60,131 Reduced 37.08%
102,055 $2.19 Billion
Q3 2025

Oct 24, 2025

BUY
$8.4 - $11.59 $392,742 - $541,890
46,755 Added 40.5%
162,186 $1.9 Billion
Q2 2025

Aug 13, 2025

BUY
$5.56 - $9.79 $641,796 - $1.13 Million
115,431 New
115,431 $1.07 Billion

Others Institutions Holding IMNM

About Immunome Inc.


  • Ticker IMNM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 12,127,400
  • Market Cap $208M
  • Description
  • Immunome, Inc., a biopharmaceutical company, discovers and develops antibody therapeutics for oncology and infectious disease. The company's lead oncology program includes IMM-ONC-01, which targets IL-38 tumor-derived immune checkpoint capable of promoting evasion of the immune system. It also develops IMM-BCP-01, an antibody cocktail product ca...
More about IMNM
Track This Portfolio

Track Tema Etfs LLC Portfolio

Follow Tema Etfs LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tema Etfs LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tema Etfs LLC with notifications on news.